Ravelcare Complete Financial Statements
In FYNone, Ravelcare (RAVEL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 18.5% and ROE of 13.5%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore Ravelcare stock price data download to track price trends across different timeframes.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
RAVEL Revenue, Net Profit & EBITDA — Year-on-Year Growth
RAVEL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see Ravelcare share price screener.
RAVEL Income Statement — Revenue, EBITDA & Net Profit
Ravelcare revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 18.5%. Analyse RAVEL FII DII holdings to track promoter, FII and institutional holdings.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 27 | 25 | 22 | 4 | 1 | 0 |
| Expenses | 0 | 20 | 18 | 15 | 3 | 1 | 0 |
| EBITDA | 0 | 7 | 7 | 7 | 1 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 26.00% | 27.00% | 30.00% | 15.00% | -28.00% | -153.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 7 | 7 | 7 | 1 | 0 | 0 |
| Tax | 0 | 2 | 2 | 2 | 0 | 0 | 0 |
| Net Profit | 0 | 5 | 5 | 5 | 1 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 9.20 | 10.48 | 10.18 | 1.12 | -0.56 | -212.44 |
RAVEL Balance Sheet — Assets, Liabilities & Shareholders' Equity
RAVEL total assets ₹38 Cr, total equity ₹37 Cr, total liabilities ₹ Cr (2026) — ROE 13.5%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 38 | 13 | 10 | 2 | 0 | 0 |
| Current Assets | 10 | 7 | 2 | 2 | 0 | 0 |
| Fixed Assets | 3 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 3 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 13 | 9 | 2 | 0 | 0 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 37 | 10 | 5 | 0 | 0 | 0 |
| Share Capital | 7 | 5 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 31 | 5 | 5 | 0 | 0 | 0 |
RAVEL Cash Flow Statement — Operating, Investing & Financing
Ravelcare operating cash flow ₹-1 Cr, investing ₹1 Cr, financing ₹0 Cr, net cash flow ₹1 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | -1 | 7 | 1 | 0 |
| Investing Activities | 1 | -7 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | -1 | 1 | 0 |